Vaccine info

AstraZeneca COVID-19 Vaccine Updates

The Medical & Scientific Advisory Board of the National Blood Clot Alliance stresses the …

Read the full story
variants of the virus that causes Covid-19

Variants of the Virus that Causes COVID-19

Vaccination against COVID-19 is now made all the more important due to the emergence of …

Read the full story
covid-19 vaccination and blood clot risk

Getting Your Vaccine

Getting Your Vaccine The Centers for Disease Control and Prevention has provided guidance for …

Read the full story
Vaccine info

Vaccine Information Specific to the Clotting Community

Some important vaccine information specific to people affected by blood clots or clotting …

Read the full story

Should Athletes Concern Themselves with Blood Clots?

Written by NBCA’s Sports & Wellness Institute Advisory Committee Member Bill …

Read the full story

Preventing Hospital-Related Blood Clots

Spending time in the hospital can be a challenge for many reasons, and one of those challenges …

Read the full story

Panel Discussion: Blood Clots & Women’s Health

The Anticoagulation Forum and the National Blood Clot Alliance held a conversation about …

Read the full story

Support NBCA in Your Own Way!

Fundraising for the National Blood Clot Alliance has never been easier. Whatever your interests …

Read the full story

Sandy’s Story

I still have the notes I wrote before visiting a doctor in April 2012: I am not feeling well. …

Read the full story

Treatment Centers Specializing in Thrombosis and Thrombophilia

Below is a list of Treatment Centers Specializing in Thrombosis and Thrombophilia. They are …

Read the full story

Current News

The National Blood Clot Alliance Launches New Council for Emerging Researchers in Thrombosis (CERT)

FOR IMMEDIATE RELEASE: 07/28/2022   The National Blood Clot Alliance (NBCA), the nation’s leading nonprofit patient advocacy organization dedicated to…

The FUVID Study

The FUVID Study (Functional Characterization of Chronic Thromboembolic Venous Disease in Children) is currently open for enrollment to qualified participants.…